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Abstract
Background: Diagnosis of Chiari-like malformation-associated pain (CM-P) or clinically
relevant syringomyelia (SM) is challenging. We sought to determine common signs.
Animals: One hundred thirty client-owned Cavalier King Charles spaniels with neuroaxis
magnetic resonance imaging (MRI) and diagnosis of CM-P/SM. Dogs with comorbidities
causing similar signs were excluded with exception of otitis media with effusion (OME).
Methods: Retrospective study of medical records relating signalment, signs, and MRI
findings. Dogs were grouped by SM maximum transverse diameter (1 = no SM;
2 = 0.5-1.99 mm; 3 = 2-3.9 mm: 4 = ≥4 mm). Differences between all groups—groups
1 versus 2-4 and groups 1-3 versus 4—were investigated. Continuous variables were
analyzed using 2-sample t-tests and analysis of variance. Associations between categori-
cal variables were analyzed using Fisher's exact or chi-square tests.
Results: Common signs were vocalization (65.4%), spinal pain (54.6%), reduced activ-
ity (37.7%), reduced stairs/jumping ability (35.4%), touch aversion (30.0%), altered
emotional state (28.5%), and sleep disturbance (22%). Head scratching/rubbing
(28.5%) was inversely associated with syrinx size (P = .005), less common in group
4 (P = .003), and not associated with OME (P = .977). Phantom scratching, scoliosis,
weakness, and postural deficits were only seen in group 4 (SM ≥4 mm; P = .004).
Conclusions and Clinical Importance: Signs of pain are common in CM/SM but are
not SM-dependent, suggesting (not proving) CM-P causality. Wide (≥4 mm) SM is
associated with signs of myelopathy and, if the dorsal horn is involved, phantom
scratching (ipsilateral) and torticollis (shoulder deviated ipsilateral; head tilt
contralateral).
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malformation (human); CM-P, Chiari-like malformation associated pain; CNS, central nervous system; CSF, cerebrospinal fluid; IVD, intervertebral disc; MRI, magnetic resonance imaging; MVD,
myxomatous mitral valve disease; OME, otitis media with effusion; PSOM, primary secretary otitis media; SM, syringomyelia; SM-S, severe SM syringomyelia with a maximum transverse
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1 | INTRODUCTION
Syringomyelia (SM) is characterized by fluid filled cavities (syrinx,
syringes) within the central spinal cord. The resulting damage can
cause pain, phantom scratching, scoliosis, paresis, and sensory defi-
cits.1,2 Syringomyelia develops as a consequence of obstruction of cere-
brospinal fluid (CSF) channels, and in the dog, it is most commonly
associated with Chiari-like malformation (CM), a complex developmen-
tal malformation of the skull and craniocervical vertebrae characterized
by a conformational change and overcrowding of the brain and cervical
spinal cord, particularly at the craniospinal junction.3
Diagnosis of clinically relevant CM or SM can be challenging
because clinical signs can be nonspecific. Chiari-like malformation
alone can cause substantial morbidity and reduced quality of life3,4;
however, an objective measure for diagnosis of CM-associated pain
(CM-P) has not been translated from research studies,3 and diagnosis
is made by excluding other causes of pain together with subjective
assessment of magnetic resonance imaging (MRI).5
Chiari-like malformation/syringomyelia is most commonly reported
in the Cavalier King Charles spaniel (CKCS), and this breed is pre-
disposed to a number of other neurological conditions6 including fly
catching,7 idiopathic epilepsy,8,9 idiopathic facial nerve paralysis with
and without associated vestibular disease,10 and degenerative mye-
lopathy.11 These unrelated conditions can be misinterpreted as a
consequence of CM, SM, or both, especially as CM/SM might be
the only abnormality reported on MRI investigation as CM is ubiq-
uitous12 and SM is also common and not always associated with
clinical signs.13 In addition, some dogs have conditions that offer an
alternative explanation for the nonspecific clinical signs including
intervertebral disc (IVD) disease14 or otitis media with effusion
(OME; also known as primary secretary otitis media or PSOM).15
The presence of comorbidities increases the challenge to ascertain
what clinical signs can be attributed to each condition, and, there-
fore, making confident diagnosis and treatment recommendations
is more difficult.
Syringomyelia-associated “phantom” scratching is considered a
specific but not ubiquitous sign of SM and is associated with a
large syrinx extending to the superficial dorsal horn in the C3-C6
spinal cord segments ipsilateral to the scratching limb.16 Originally
thought to represent a paraesthesia, it is more likely to be similar
to fictive scratch reported in spinalized animals.17,18 It is also rec-
ognized that dogs with CM/SM can excessively rub or scratch their
heads or ears and that this is not necessarily associated with SM
and is not phantom scratching.4,19 The association of SM to scratching
has led to the misconception that it causes generalized pruritus, and
consequently investigation and treatment of skin disease could be
missed.20
The aim of this study was to characterize retrospectively the clini-
cal and behavioral signs of CM-P and SM and relate these to maxi-
mum syrinx transverse diameter. It is with a view to translating this
data into a tool which can be used in prospective studies into the
treatment, diagnosis, and genetics of CM/SM.
2 | MATERIALS AND METHODS
As a preparatory work for this retrospective study, the medical
records of 10 CKCS that had been managed exclusively by CR for
3 years or more were examined. An inclusion criterion was regular
examination (minimal of every 6 months) until the time of death. The
medical notes were reviewed in detail, and all clinical signs were
recorded with the aim of using these as baseline categories in the
main study. These dogs were not used in the final analysis as their
medical records predated the current MRI protocol.
2.1 | Animals
Medical records were searched for all CKCS examined by CR during a
5-year period (2013-2017) and that had full brain and spinal MRI.
Dogs that did not have a primary diagnosis of CM-P or SM were
excluded. Diagnosis of SM and CM-P was made according to previ-
ously defined criteria.5 The date of birth, age at last MRI, sex, neuter
status, and weight were recorded. The entire medical history was
examined, and all clinical and behavioral signs were recorded. The
assessment was made by the same clinician who had examined the
dogs originally and made all the follow-up examinations. The behav-
ioral and clinical signs were recorded under the following categories
(Table 1): vocalization, spinal pain, activity, stairs/jumping, change in
emotional state, sleep, other pain behaviors/signs, possibly unrelated
behaviors/signs, scratching or rubbing of the head or ears, phantom
scratching, neurological examination abnormalities, and comorbidities.
If scratching or rubbing was noted, then the area/side to which the
dog scratched/rubbed was recorded. If scoliosis was documented,
then the direction of head and spine rotation was recorded.
2.2 | Image analysis
Assessment of MRI was performed separately before and after the
analysis of medical records, and the results were subsequently com-
bined. The images were not anonymized. For each dog, the MRI imag-
ing was reviewed for adequate quality and appropriate sequences
(brain and whole spine imaging in T2- and T1-weighted sagittal and
T2- (high field MRI) and T1- (low field) weighted transverse images
with transverse images centered on the widest point in the syringes
(if present) within the cervical, thoracic, and lumbar spinal cord and
also transverse imaging of any other lesion (eg, sites of IVD). Most
dogs were imaged with a 1.5 Tesla unit (Symphony Maestro Class,
Siemens, Enlargen, Germany); however, 23 dogs were imaged with a
0.2 Tesla MRI machine (Esaote Vet MRI, Genova, Italy). A measure-
ment of the maximum transverse width of syrinx (if present) was
made, and any spinal cord superficial dorsal horn involvement by the
syrinx, including side, was noted using the methods described previ-
ously (syrinx width17; superficial dorsal horn involvement16). If both
spinal cord superficial dorsal horns were involved by the syrinx, a sub-
jective assessment of which side had more severe involvement was
made. Any other MRI findings were recorded including the presence
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TABLE 1 Behavioral and clinical signs of Chiari-like malformation and syringomyelia in Cavalier King Charles spaniels
Category Subcategory Notes
Vocalization Spontaneous yelping or when changing
position when recumbent
Yelping (sudden, short, high sound) described by owner as
“out of now-where”, spontaneous or when moved whilst
lying resting or asleep
Postural Yelping when lifted under sternum, on rising, or both
Defecation Vocalization during defecation
Scratching vocalization during scratching
Spinal pain Cervical Hyperesthetic to palpation in the cervical region
Thoracolumbar Hyperesthetic to palpation in the T1-L4 region
Lumbosacral Lumbosacral or caudal lumbar (L5-L7) hyperesthesia
Activity Reduced exercise Described as exercise intolerant or unwilling to exercise.
BOAS and heart disease ruled out as alternative causes
Lethargy Described as lethargy/increased sleeping
Stairs/jumping Stairs/jumping Described as refusing/unwilling/hesitation/
difficulty/vocalization when jumping, doing stairs,
or both
Change in emotional
state/behavior
Greeting Yelping, refusal to get up and greet owner, or both
Aggression To other dogs/people
Timid/anxious Described as such by owner
Withdrawn Described as withdrawn/avoiding people/decreased
interaction/hiding/lethargic/decreased playing
Sleep Sleep disruption Described as being restless in the night or having disturbed
sleep
Other pain
behaviors/ signs
Licking limb/paw Without evidence of skin or joint disease
Touch or ears/head or neck Owner reported and specified body part and that tolerated
touch, grooming elsewhere, or both
grooming aversion 1–2 limbs or paws
sternum, flank
Sleeping elevated or unusual head posture Attempt made to rule out BOAS
Abnormal awake head/neck posture Head held down or reluctant to move neck
Pain face Described by owner that change facial expression that
suggested pain
Squinting/avoiding light Described by owner as light avoiding/closed eyes/watery
eyes/squinting Schirmer tear test performed to rule out
Keratoconjunctivitis sicca
Possibly unrelated
behavior
Repetitive tongue licking Thought more likely to reflect gastroesophageal pain
Repetitive barking Through to reflect anxiety but not necessarily due to CM/SM
Scratching, rubbing
head or ears, or both
None Excluded cases that also had ear/skin disease (except OME)
Phantom Scratching Phantom Scratching Rhythmic scratching action towards, but not making contact
with the skin, together with a curvature of the body and
neck towards the foot. Induced by light rubbing to the neck
or ear region. Side (s) recorded
Neurological
abnormalities
Weakness Anatomical location recorded
Muscle atrophy Anatomical location recorded
Postural responses decreased Anatomical location recorded
Hypermetria Limbs recoded. Likely only recorded if considered more than
usual for the breed
Scoliosis/cervicothoracic torticollis Side head tilted down and shoulder pushed out recorded
(Continues)
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of OME/PSOM which was defined as the presence of uniform
hyperintense material within 1 or both tympanic bullae on T2-weighted
imaging with no changes suggesting infection (eg, thickening of the
integument).
2.3 | Further inclusion/exclusion before analysis
All medical comorbidities were recorded. Dogs with significant IVD dis-
ease were excluded from the study. This was defined as an MRI finding
of IVD herniation with impingement of the spinal cord or nerve root or
IVD degeneration and any sign/history suggesting spinal pain. However,
dogs with clinically insignificant IVD degeneration/minor protrusion were
included in the study. This was defined as no spinal pain on neurological
examination and no history of vocalization, difficulty jumping/doing
stairs, lameness or exercise intolerance, and an MRI finding of 1 or more
IVD with loss of signal of the nucleus pulposus on T2-weighted imaging
with variable protrusion of the annulus fibrosus that might result in the
displacement of the dorsal longitudinal ligament but with no spinal cord
or nerve root impingement. Dogs with skin disease, ear disease, or both
were excluded from the study except when the diagnosis was historical
and had responded to appropriate management and only if there were
no current signs of scratching, rubbing, or licking. The exception was the
presence of OME/PSOM as this variable would be analyzed separately.
Dogs that had other current or historical comorbidities that could be a
possible alternative explanation for a 1 or more clinical or behavioral
signs were excluded.
2.4 | Analysis
The dogs were grouped according to maximum transverse central
canal or syrinx size as follows: group 1 with no SM or central canal
dilatation (CCD); group 2 with CCD and a maximum transverse central
canal of 0.50-1.99 mm; group 3 with mild SM and a maximum trans-
verse syrinx size of 2-3.99 mm; group 4 with severe SM (SM-S) with a
maximum transverse central canal or syrinx size ≥4 mm. Potential dif-
ferences between the groups were analyzed in 3 ways as follows:
(1) The difference among all 4 groups; (2) The difference between
dogs without SM and dogs with a CCD/SM transverse diameter
≥0.5 mm, that is, groups 1 versus groups 2-4; and (3) the difference
between dogs with SM-S and other dogs, that is, group 4 versus
groups 1-3. Continuous variables were analyzed using 2-sample t-tests
and analysis of variance as appropriate, and all associations between
categorical variables were analyzed using either Fisher's exact or chi-
square tests. A 5% level of significance was set, and all analyses were
performed on IBM SPSS v24.0.
3 | RESULTS
3.1 | Animals
The initial search of medical records revealed 216 CKCS with a pri-
mary diagnosis of CM-P, SM, or both, but after exclusions the final
cohort was 130 CKCS (54 male, 76 female). The excluded dogs were
as follows: 12 dogs with comorbidity of IVD disease; 11 dogs with
comorbidity of skin disease; 30 dogs with other comorbidities which
could cause exercise intolerance, pain, or both including brachyce-
phalic obstructive airway disease (BOAS), orthopedic disease, or both;
33 dogs because of inadequate MRI study.
The mean syrinx size was 4.34 mm (SD ±2.34) distributed as
detailed in Table 2 with 11 dogs in group 1, 15 dogs in group
2, 20 dogs in group 3, and 84 dogs in group 4. Table 3 and Figures 1
and 2 summarize the group statistics for age and bodyweight at MRI.
TABLE 1 (Continued)
Category Subcategory Notes
Comorbidities Intervertebral disc disease Excluded if spinal pain, compression spinal cord or nerve root,
or both
Skin disease Excluded unless separate historical diagnosis which resolved
on treatment, for example, fleas
OME/PSOMS Left/right/bilateral recorded
Other where CM/SM was the primary, first diagnosis, or both Recorded not excluded unless condition a differential for one
or more clinical sign
Other primary diagnosis Cases excluded
Bold terms indicates the exclusions and the OME category for which p values are given. Behavioral and clinical signs recorded from CKCS affected by
CM-P and SM with explanatory notes on how these signs were identified, recorded, or both.
TABLE 2 Descriptive statistics of syrinx size
Group
Number
of dogs Mean (mm) SD (mm) Range (mm)
1 (no SM) 11 0 0 0
2 (CCD 0.5–1.99 mm) 15 1.22 0.43 0.50-1.98
3 (SM 2.00-3.99 mm) 20 2.30 0.66 2.00-3.97
4 (SM ≥4 mm) 84 5.80 1.20 4.00-9.00
Total 130 4.34 2.34 0-9.00
Distribution of mean maximum transverse diameter of the syrinx or
central canal in 130 CKCS with CM-P and SM.
Abbreviations: CCD, central canal dilatation; CKCS, Cavalier King Charles
spaniel; CM-P, Chiari-like malformation associated pain; SM,
syringomyelia.
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TABLE 3 Group statistics for age and
weight in CKCS with and without
syringomyelia
Syrinx presence Number of dogs Mean SD SE mean
Age_MRI, y NO 16 4.16 3.00 0.75
YES 113 4.88 2.26 0.21
Weight, kg NO 16 10.23 3.05 0.76
YES 100 9.51 2.20 0.22
Group statistics for age at most recent MRI and weight in CKCS with and without SM (group 1 versus
groups 2-4). From the original 130 dog cohort, the age and weight was missing from the medical records
for 1 and 14 dogs, respectively.
Abbreviations: CKCS, Cavalier King Charles spaniel; MRI, magnetic resonance imaging; SM,
syringomyelia.
F IGURE 1 Distribution of age in CKCS with CM-P and SM
Age at last MRI (years). Groups according to maximum transverse
diameter of syrinx 1 = no SM; 2 = 0.5-1.99 mm; 3 = 2-3.9 mm:
4 = ≥4 mm. Top row: Comparison among all 4 groups divided according
to maximum transverse diameter of the syrinx or central canal (P = .60).
Middle row: Difference between dogs without SM and dogs with a
CCD/SM transverse diameter ≥0.5 mm, that is, group 1 versus groups
2-3 (P = .26). Bottom row: Difference between dogs with SM-S
(SM ≥4 mm) and other dogs (SM <4 mm), that is, group 4 versus groups
1-3 (P = .29). From the original 130 dog cohort, age was missing from
the medical records for 1 dog: CKCS, Cavalier King Charles spaniel; CCD,
central canal dilatation; SM, syringomyelia; SM-S, severe syringomyelia
with a maximum transverse syrinx diameter ≥4 mm
F IGURE 2 Distribution of weight in CKCS with CM-P and SM
Weight (kg) at MRI. Groups according to maximum transverse diameter
of syrinx 1 = no SM; 2 = 0.5-1.99 mm; 3 = 2-3.9 mm: 4 = ≥4 mm. Top
row: comparison among all 4 groups divided according to maximum
transverse diameter of the syrinx or central canal (P = .17). Middle row:
difference between dogs without SM and dogs with a CCD/SM
transverse diameter ≥0.5 mm, that is, group 1 versus groups 2-3
(P = .25). Bottom row: difference between dogs with SM-S (SM ≥4 mm)
and other dogs (SM <4 mm), that is, group 4 versus groups 1-3 (P = .93).
From the original 130 dog cohort, weight was missing from the medical
records for 14 dogs: CKCS, Cavalier King Charles spaniel; CCD, central
canal dilatation; SM, syringomyelia; SM-S, severe syringomyelia with a
maximum transverse syrinx diameter ≥4 mm
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The mean bodyweight was 9.61 kg (SD ±2.33 kg). The mean age at
the last MRI was 4.79 years (SD ±2.36 years). The sex distribution
was group 1 (3 female, 8 male); group 2 (9 female, 6 male); group
3 (14 female, 6 male); group 4 (20 female, 34 male; between all
groups: P = .14; between dogs with and without SM (group 1 versus
group 2-4): P = .12; between dogs with SM-S and those with mild or
no SM (group 4 versus group 1-3): P = .88. Of the total sample,
88 dogs were neutered (55 female 33 male) and 14 dogs (3 female
11 male) were entire; neuter status was not specified in the records of
28 dogs (neuter status between groups P = .13).
3.2 | Clinical and behavioral signs
The frequency of the clinical signs and whether this clinical sign was
related to syrinx presence or size are illustrated in Tables 4 and 5.
Clinical and behavioral signs of pain were common in dogs diagnosed
with CM-P and SM but were not SM dependent.
The most common historical sign was vocalization, recorded in 65.4%
dogs (55.3% spontaneous or when changing position when recumbent,
29.2% postural, 2.3% during defecation). The presence of vocalization
was not related to syrinx presence or size with the exception of postural
vocalization (yelping when picked up under sternum), which was more
common in groups 1-3, that is, dogs with no or mild SM (P = .04).
The next most common sign was spinal pain present in 54.6%
of dogs (32.3% cervical, 36.9% thoracolumbar, 12.3% lumbosacral).
Spinal pain, at any site, was not related to syrinx presence or size as
defined by maximum transverse width.
A change in activity was recorded in 37.7% of dogs with 33.8%
reported as having reduced exercise tolerance, 12.3% reported as
lethargic, and 8.5% described as both lethargic with reduced exercise
tolerance. These signs were not related to syrinx presence or size.
Refusal/being unwilling/hesitating/difficulty, vocalization, or both when
jumping, doing stairs, or both were also a common historical finding
being reported in 35.4% of dogs and was also not related to syrinx
presence or size. A change in emotional state described as becoming
more timid, anxious, withdrawn, or aggressive was reported in 28.5% of
dogs, and 22.3% of dogs had disrupted sleep characterized by nighttime
restlessness. None of these signs was related to syrinx presence or size
with the exception of withdrawn behavior, which was more common in
CKCS with SM-S (P = .03); however, there was a low number of dogs
for this variable; therefore, this finding might not be true.
Other pain behaviors, not related to syrinx presence or size, were
reported in 43.1% of dogs of which the most common was aversion
to touch or grooming which was present in 30.0% of dogs, with the
ears, head, and neck region being the specific area in 25.4% of dogs.
The only signs that were significantly associated with syrinx pres-
ence and size were scratching (phantom and scratching or rubbing of
the head or ears), scoliosis, postural deficits, and weakness. Of these
phantom scratching (P ≤ .001), scoliosis (P ≤ .001), postural deficits
(P = .004), and weakness (P ≤ .001) were associated with SM-S, that is,
large syringes with a maximum transverse width ≥4 mm. All affected
dogs with these neurological signs were in the SM-S group 4. Phantom
scratching was seen in 67% of group 4 dogs and was not seen in groups
1-3. There was a correlation with mid-cervical superficial dorsal horn
involvement and the side of phantom scratching with 3 exceptions,
which were dogs reported to scratch to the sternum, that is, not
directed toward a side. One of these 3 dogs had a thoracic syrinx with
bilateral dorsal horn involvement in the T1-T2 region with only minor
cervical spinal cord involvement (CCD only); the other 2 dogs had uni-
lateral dorsal horn involvement through the cervical and thoracic spinal
cord. There were 12 dogs that phantom scratched at both sides of the
neck, and for these dogs, there was bilateral superficial dorsal horn
involvement in the mid-cervical region with subjectively more severe
involvement of the superficial dorsal horn ipsilateral to the side most
scratched. Phantom scratching was recorded in all dogs where the syr-
inx width was ≥6.4 mm. By contrast, scratching or rubbing of the head
or ears was inversely associated to syrinx size (P = .005), and although
present in 28% of the population, it was less common in dogs in the
SM-S group 4 category (P = .003).
Scoliosis was found in 27% of group 4 SM-S CKCS, and this is bet-
ter described as a cervicothoracic torticollis with a twisting so that the
head deviated ventrally contralaterally, and the shoulder was pushed
out ipsilateral to the cervical superficial dorsal horn involvement.
Weakness was reported in 39% of group 4 SM-S CKCS and was most
commonly reported as of 1 or both thoracic limbs; tetraparesis with
the thoracic limbs more severely involved; or could also involve the
core muscles with the dog presenting with lordosis. Muscle atrophy
was only recorded in dogs in the SM-S category, but the frequency
was low (5 dogs) and did not achieve significance.
3.3 | Comorbidities
The study cohort had following comorbidities: BOAS (10.0% of popula-
tion); chronic or historical pancreatitis (6.2%); inflammatory bowel dis-
ease, chronic diarrhea, or both (6.9%); keratoconjunctivitis sicca (6.9%);
myxomatous mitral valve disease (MVD) (18.5%); oral eosinophilic granu-
loma (0.8%); previously excised type 1 dermoid sinus (0.8%); minor
orthopedic disease, for example, grade I patellar luxation (12.3%); epi-
lepsy (3.8%); fly catching (0.8%); episodic falling (1.5%); and historical skin
disease (3.1%). Cases where these comorbidities could be a possible
explanation for the clinical signs, for example, scratching with a comor-
bidity of skin disease, had already been excluded from the study popula-
tion. Some CKCS developed new (presumed) unrelated neurological
conditions during the study period as follows: head and neck myoclo-
nus21 (13.1%), cognitive function deficit (0.8%), orthostatic pelvic limb
tremor (3.8%), uncategorized paroxysmal events (1.5%), facial nerve
paralysis (3.8%), vestibular disease (3.8%), and deafness (0.8%). None of
the comorbidities was significantly associated to any of the 4 groups
with the exception of myoclonus in which 12 of 17 cases were in group
4 (P < .001). Otitis media with effusion (PSOM) was present in 44.6% of
the dogs with the SM-S (SM ≥4 mm) group having 48% of the cohort
with 1 or both ears affected (P = .27) and 30% having bilateral OME
(P = .14). Otitis media with effusion (PSOM) was analyzed separately for
an association to clinical signs of scratching or head rubbing (P = .98).
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TABLE 5 Distribution of behavioral and clinical signs in CKCS with clinically relevant CM or SM
Category Sub category Dogs (%)
Presence and size of SM (p value)
Size
Presence <0.5 mm/
≥0.5 mm
SM-S < 4 mm/
≥4 mm
Vocalization Spontaneous yelping or when changing
position when recumbent
55 .44 .29 .26
Postural 29 .13 .56 .04
Defecation 2 .57* .33 .99*
scratching 5 .51 .60 .42
Either/both spontaneous or postural 65 .26 .58 .19
Spinal pain Cervical 32 .07 .15 .15
Thoracolumbar 37 .78 .59 .99
Lumbosacral 12 .55* .42 .42
Any spinal pain 55 .65 .29 .38
Activity Reduced Exercise 34 .36 .26 .23
Lethargy 12 .46* .11 .64
Both (lethargic and reduced exercise) 8 .86* .62 .99
Any activity change 38 .51 .78 .49
Stairs/jumping Refusal/ hesitation/difficulty 35 .16 .99 .22
Change in emotional
state/behavior
Greeting 5 .43* .55 .67*
Aggression 8 .36* .36 .16
Timid/Anxious 14 .28* .70 .11
Withdrawn 13 .12* .13 .03
Any behavior change 28 .42 .56 .29
Sleep Sleep disruption 22 .30* .12 .078
Other pain behaviors Touch/grooming aversion ears/head and/or neck 25 .92 .99 .99
1–2 limb/paw 3 .52* .99 .30
sternum or flank 5 .65* .60 .70
Abnormal awake Head/neck posture 8 .26* .36 .10
Sleeping elevated or unusual head posture 5 .86* .60 .99
Squinting/Avoiding light 5 .66* .99 .42
Licking limb/paw 4 .42* .99 .16
Pain face 3 .52* .99 .30
1 or more pain behaviors/signs 43 .37* .30* .12*
Possibly unrelated
behavior
Repetitive tongue licking 6 .97* .99 .99
Repetitive barking 2 .77* .99 .54
Scratching and/or
rubbing head
or ears
28 .005 .77 .003
Phantom Scratching Phantom Scratching 43 <.001 <.001 <.001
Neurological
abnormalities
Weakness 25 <.001 .01 <.001
Muscle atrophy 4 .42* .99 .16
Postural responses decreased 10 .05* .367 .004
Hypermetria 10 .69* .99 .99
Scoliosis/cervicothoracic torticollis 18 .002 .07 <.001
Any neurological abnormality 35 <.001 .01 <.001
(Continues)
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4 | DISCUSSION
As acknowledged in previous studies,4,18 CM-P and SM are painful;
however, this study showed that the signs of pain are not SM depen-
dent suggesting CM-P causality or an epiphenomenon. Signs common
in all groups were vocalization; reduced activity; reduced
stairs/jumping ability; spinal pain; change in emotional state; sleep dis-
turbance; aversion to touch and scratching; and rubbing head or ears.
Signs specific to SM were only seen with large syringes, consistent with
the neurolocalization of the cavity, and included phantom scratching,
scoliosis with motor and sensory deficits. Our study aimed to determine
common clinical and behavioral signs associated with CM-P and SM for
further prospective studies, and we particularly wanted to ascertain
what signs might indicate CM-P as diagnosis of this is challenging and
made by excluding other causes of pain and head rubbing together with
appropriate MRI changes.5 We made a comprehensive analysis of the
owner reported signs and clinical findings in a comparatively large
cohort of 130 client owned dogs with rigorous inclusion and exclusion
criteria and without the bias created by active recruitment of cases.
However, the reader is recommended to be cautious in making conclu-
sions, as the findings are the observations of 1 individual and reports
from the owner and therefore subject to bias. A decision was made to
limit the study to animals under the care of single veterinary surgeon
who had over 20 years' experience of CM/SM as it was more likely that
the history taking, clinical examination, and medical note annotation
were detailed and consistent among dogs. However, the authors'
acknowledge that this does introduce a bias of the opinion of that indi-
vidual especially as the same individual analyzed the MRI, albeit sepa-
rately to and after analysis of the clinical records. There could be a bias
in the exclusion, for example, removing the dogs with scratching that
had both SM and skin disease. In addition, including so many covariates
in 1 study might have influenced the significance levels. Therefore, the
findings in this study should be verified by other independent studies
and perhaps concentrate on more specific covariates.
The most common sign reported by owners of CM-P and SM
affected dogs is vocalization. More than 1 in 2 dogs were reported to
yelp, described as being spontaneous or following/during movement
especially when recumbent and during the night. Classically, human
patients with the analogous condition Chiari type I malformation (CM1)
have an occipital or suboccipital headache exacerbated by cough and
other Valsalva maneuvers or exertion.22 However, many patients report
worse headaches when supine because fluid redistributes towards the
head.23-25 A similar headache is reported with benign intracranial
hypertension24,25 and is a possible explanation for the signs suggesting
pain reported in CM-P-affected dogs. Vocalization when lifted by the
sternum in CM-P-/SM-affected dogs has been reported anecdotally for
many years26 and is hypothesized to be a failure to equilibrate intracra-
nial pressure due to obstruction of CSF pathways and the micro-
gravitational effects when being lifted rapidly. More recently, this clini-
cal sign was documented as occurring in 1 in 3 dogs with CM and SM,4
which is a similar proportion to this study (29.2% postural pain). Neither
study found an association with the presence or severity of a syrinx. In
this study, this sign was more common in a CKCS with no or mild SM
suggesting that this sign might be associated with CM-P.
Spinal pain at 1 or more sites was found in 54.6% of dogs; however,
this was not related to syrinx size or presence. Indeed, for groups 1 and
2 (26 dogs with no syrinx or with CCD), 14 had cervical pain, 10 had
thoracolumbar pain, and 3 dogs had caudal lumbar/lumbosacral pain. In
the total cohort, thoracolumbar pain was more common than cervical
pain (36.9% versus 32.3%) and caudal lumbar/lumbosacral pain was
seen in a minority of patients (12.3%). This finding of more caudal spinal
pain does not have a clear neuroanatomical explanation but has been
documented previously.4,26 This sign is difficult to be compared to
CM1 as a significant number of human patients have comorbidities that
could also result in back pain such as IVD disease, fibromyalgia, and
Ehlers-Danlos syndrome.27 Further studies are required to investigate
this finding in dogs and what morphological changes predict it (if any).
This study did not assess the spinal cord distribution of the syrinx
(if present). Defining total involvement of the spinal cord by the syrinx
is difficult, for example, it is challenging to quantify and compare vary-
ing diameter of the syrinx, CCD, and the presence of presyrinx along
the spinal cord. However, this could be studied separately in prospec-
tive studies in a larger cohort. Other behavioral signs of pain were
reported, with 43.1% of the cohort having signs suggesting head, limb,
or flank pain of which the most common was aversion to touch of the
ears, head, or neck. Signs of pain from stimuli that do not normally
TABLE 5 (Continued)
Category Sub category Dogs (%)
Presence and size of SM (p value)
Size
Presence <0.5 mm/
≥0.5 mm
SM-S < 4 mm/
≥4 mm
OME/PSOMS Any/both ears 45 .59 .11 .27
Left 33 .35 .09 .19
Right 35 .89 .42 .20
Bilateral 25 .46 .36 .14
The percentage of the total cohort of 130 CKCS with each behavioral or clinical sign and the potential differences between the groups as follows: Size—the
difference among all 4 groups; Presence—the difference between dogs without SM and dogs with a CCD/SM transverse diameter ≥0.5 mm, that is, group 1
versus groups 2–4; SM-S: the difference between dogs with SM-S and other dogs, that is, group 4 versus groups 1–3. Significant P-values are in bold.
Abbreviations: CKCS, Cavalier King Charles spaniel; CCD, central canal dilatation; OME, otitis media with effusion; PSOM, primary secretary otitis media;
SM, syringomyelia; SM-S, severe syringomyelia with a maximum transverse syrinx diameter ≥4 mm.
*Test not robust due to small frequencies.
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cause pain have been previously associated with CM-P and SM and are
thought to represent allodynia.17,28
Scratching, rubbing the head or ears, or both was 1 of the more
common signs, seen in 28.5% of the cohort, and has been previously
described in dogs affected by CM-P and SM.4,26 Why this behavior
might be seen is obviously speculative. One study showed that 81%
of human patients with CM1 reported aural fullness and 81% reported
tinnitus, symptoms usually attributed to ear disease.29 We suggest
this as 1 possible explanation for why dogs with CM-P might rub their
ears. It was interesting that OME (PSOM), something that has been
reported to cause ear discomfort,30 was not significantly associated
with head/ear rubbing or scratching in the CM-P/SM cohort. It can be
difficult for veterinarians to know whether signs of ear discomfort are
attributed to OME or CM-P and consequently unclear whether to
advise myringotomy and/or placement of tympanostomy tube(s).31
Otitis media with effusion is a sequel of brachycephalic conformation
and poor drainage of the middle ear,30,32,33 and although drainage of
the material might improve signs, there is often recurrence because the
predisposing factors are not addressed.30 This study suggests that
OME is common in CM-P- and SM-affected dogs, and caution should
be observed before attributing signs of ear rubbing with OME (PSOM).
Other common signs that were not related to syrinx presence or
size were changes in activity and behavior which suggested avoidance
or pain when jumping or doing stairs. This could have a variety of
explanations, but in comparison to CM1, 96.1% of patients report
impact in 1 or more areas of daily living and physical activity34 and
activity headache is common.35
A behavioral change was reported in almost 1 in 3 dogs (28.5%).
Again, this could have a variety of explanations, but pain can negatively
affect a dog's emotional state and increase anxiety,36 lower the threshold
for aggressive behavior or increase the likelihood of a protective/
defensive response,37 or both. A questionnaire-based behavioral
analysis found that CM-P/SM-affected CKCS were more likely than nor-
mal CKCS to show stranger-directed fear, nonsocial fear, separation-
related behavior, attachment behavior, anxiety (described as excitability
in the study), had poor ability to settle, and were more reluctant to
exercise.36
Pain-related sleep disruption is important morbidity affecting qual-
ity of life and is recognized in other painful conditions in the dog such
as osteoarthritis.38 In this study, sleep disruption was reported in
approximately 1 in 5 dogs. Pain sensitivity and sleep have a mutual
deleterious influence; for example, in humans, insomnia significantly
increases the risk for reduced pain tolerance.39 It is recommended
that human patients with neuropathic pain have assessment of sleep,
mood, and functional capacity in addition to simple pain relief scales
(eg, numerical rating scale or visual analog scales) especially when
assessing treatment effects.40 One comorbidity that was not fully
investigated in this retrospective study was whether sleep apnea
could be a complicating factor. Patients with CM1 are predisposed to
sleep disorders and have a high prevalence of sleep apnea-hypopnea
syndrome.41 Cavalier King Charles spaniels are also predisposed to
BOAS, and although an attempt was made to exclude these dogs,
none of the dogs with sleep disruption had whole-body barometric
plethysmography.42
The study suggested that the presence of SM per se might not be
associated with certain signs of pain; however, no attempt was made
to quantify the signs of discomfort or an individual dog's quality of life
as this was beyond the scope of this retrospective study. In other
words, it is possible that SM-affected dogs had similar signs to dogs
with CM-P but that the signs in SM affected dogs were more frequent
or severe. There was a suggestion that this might be so, for example,
SM-S dogs were more likely to be withdrawn. A recommendation
from this study is to use the clinical signs identified to develop a pro-
spective quality-of-life scoring system.
The study found that wide (≥4 mm) SM results could result in a mye-
lopathy with sensory and motor signs that localize to the level of the spi-
nal cord affected by the syrinx. However, gait disturbances could be mild
even with extensive SM. Specific signs that were suggestive of a wide
cervical syringe was phantom scratching and cervicothoracic torticollis
(scoliosis). Phantom scratching is described a rhythmic scratching action,
without making contact with the skin, together with a curvature of the
body and neck towards the foot.16 It can be induced by lightly rubbing a
defined area of skin, typically on the neck. This light touch–induced
scratch reflex makes walking on a collar difficult. Phantom scratching also
be triggered by excitement or anxiety. Although considered a specific
sign of SM, this sign is not universal and is associated with large syrinx
extending to the superficial dorsal horn in the C3-C6 spinal cord seg-
ments (C2-C5 vertebrae) ipsilateral to the scratching limb.16 Originally
thought to represent a paraesthesia, current thinking is that it is more
similar to fictive scratch reported in spinalized animals17,18 and hypothe-
sized due to alteration of dorsal horn input to the scratching central pat-
tern generator.16 Our study also found that phantom scratching was
associated with large syringes and ipsilateral extension of the syrinx to
the region of the cervical cord dorsal horn. Phantom scratching was
observed in approximately 2/3 of CKCS with SM-S and in all dogs where
the syrinx was ≥6.4 mm. Our study findings further suggest that phan-
tom scratching is highly unlikely with small syringes. A minority of the
dogs (3) had a phantom scratching action to the sternum, and there was
a suggestion that this might be involved with thoracic spinal cord dorsal
horn involvement, a hypothesis which should be investigated in a larger
cohort.
Cervicothoracic torticollis (scoliosis) was also a sign exclusive to
and common in the SM-S group. This sign has previously been associ-
ated with wide syringes in the dorsal spinal cord, and our study
supported an association to superficial dorsal horn involvement with a
corkscrew deviation of the head and neck so that the head is twisted
ventrally contralateral to and the shoulder twisted and pushed out
ipsilateral to the side of dorsal horn involvement. Cervicothoracic tor-
ticollis is thought to be due to asymmetrical damage of the dorsal gray
column, over a number of spinal cord segments, resulting in an imbal-
ance of afferent proprioceptive information from the cervical neuro-
muscular spindles.17,43
Comorbidities were common and not unexpected given the breed
disposition to MVD,44 pancreatic disorders,45 keratoconjunctivitis sicca,46
and other neurological disorders.6,21 Other than ascertaining that a group
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was not predisposed to a certain comorbidities, detailed analysis was not
preformed because of the retrospective and likely incomplete nature of
the study, for example, MVD was the most common comorbidity present
in approximately 1 in 5 CKCS but cannot be translated as the lifetime risk
of a CM-/SM-affected dog having MVD because this disease is more
common in older CKCS.44 The study did suggest that myoclonus was
more commonly seen within the SM-S group. However, caution is
observed because numbers were small and a previous study of 40 CKCS
with myoclonus did not suggest it was more common with SM-S.21
5 | CONCLUSION
Our results suggest any tool developed for ascertaining quality of life in
CM-P and SM should have specific questions on signs suggesting
discomfort, scratching/rubbing (including character/site), sensitivity to
touch, activity, ability to jump and climb stairs, emotional state, and sleep.
The study further suggests that SM-specific signs are phantom
scratching, scoliosis, and sensory and motor signs that can be related to
spinal cord damage by the syrinx and are associated with large syringes
(transverse width ≥4 mm). Non-SM-specific signs include vocalization
(described as without obvious trigger, when shifting position when
recumbent and when being lifted under the sternum to a height), spinal
pain, head and ear rubbing or scratching, aversion to touch, refusal or dif-
ficulty jumping or doing stairs, exercise intolerance/reduced activity,
sleep disruption, or behavioral change described as becoming more anx-
ious, timid, aggressive, or withdrawn. These non-SM-specific signs could
reflect CM-P. Although possible variables for the tool have been identi-
fied, interrelationships between them would have to be taken into
account in a multivariate sense when modeling.
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